Brian Nowosielski

Harini Bupathi, Esq, discusses the basis of PBM audits, why they exist, and how pharmacies can anticipate them.

With social determinants of health impacting patient outcomes, researchers assess the viability of community pharmacy partnerships for addressing atrial fibrillation.

In a recent PSG-sponsored webinar, experts present on the growing push toward new-wave pharmacy benefit managers models in pharmacy benefits design.

As clinical roles expand, the need for robust pharmacy infrastructure to streamline workflows and ensure medication access has never been more critical.

Despite the boom in prescription weight loss medications, the management of OTC alternatives is still paramount in improving patient outcomes and reducing adverse events.

In part 2 of our interview with Julia Vu, PharmD, she delves into the AI space within pharmacy practice while touching on the industry’s role in boosting rural health outcomes.

Reports state that everyone from “shadowy online vendors” to physicians and nurses is illegally promoting the drug before it receives proper FDA approval.

This episode explores the true price of commitment to a dream or vision, explaining how anything less than full dedication can lead to failure and why small wins are essential for perseverance.

Alongside malnutrition instances and measles cases, researchers review pneumonia disease burden and immune vulnerability across high-risk pediatric groups.

Based on data from the ADA’s 2026 Scientific Sessions, glucagon-like peptide-1s are continuing to revolutionize the cardiometabolic disease landscape.

Julia Vu, PharmD, joins to discuss industry-impacting NCPDP standards and how they are introducing new processes for medication delivery.

As pneumococcal disease continues to rise since the COVID-19 pandemic, researchers looked at the need to escalate the management of serotype surveillance and vaccine coverage.

The AI-led initiative was designed to conduct audits and ensure appropriate distribution of health care funds for federal programs.

In an evolving health care landscape bringing all providers into a primary care team, diabetes is no different and the pharmacist community can offer so much for patients.

Recent research data assessed the potential use of GLP-1s for reducing the progression of total knee arthroplasty.

Episode 11 addresses recent changes to the AACE diabetes guidelines and what pharmacists need to do to stay informed.

In part 2 of our interview with Sandra Leal, PharmD, MPH, she explored the ADA Standards of Care and how pharmacists are positioned to assist in interoperable diabetes management.

Exploring both the PCV20 and PCV21 pneumococcal vaccines, researchers compare the differences in immune effects between patients at 50 and 65 years old.

With insights from executives working around the clock to advance the pharmacy profession, our experts predicted what the landscape will look like following the Consolidated Appropriations Act of 2026.

Pharmacist and diabetes expert Sandra Leal, PharmD, MPH, joins to discuss the importance of engaging pharmacists within primary care diabetes teams.

In a meta-analysis conducted between 2013 and 2023, researchers explore the overall impact of interventions geared toward boosting pneumococcal vaccination rates.

Featuring pharmacist and entrepreneur Sam Maddula, PharmD, this episode explores some key legislative and regulatory insights regarding owning and operating a pharmacy business.

Represented by Frier Levitt, multiple hospital systems filed lawsuits on May 21, 2026, targeting a variety of entities existing under CVS Health.

In a health care landscape of silos and fragmentation, especially in the menopause space, pharmacists have increasingly provided their efforts to better care coordination for their communities.

From supporting MTM services to reaching unhoused populations, the 340B program is a powerhouse for patient care, access, and affordability.

This month’s event will explore policy, people, and profitability, and how pharmacy businesses can transform these factors toward actionable solutions.

In this episode, host Taylor Watterson, PharmD, PhD, provides a deeper look into workplace fatigue and the metrics used to calculate and facilitate it.

In part 2, Miller further breaks down the fragmentation of menopause care within today’s health care system and how pharmacists are uniquely positioned to fill in long-standing care gaps.

Across rural US community pharmacies, researchers explore the common barriers and facilitators to pneumococcal vaccine uptake.

Two separate bills were marked up in House committees last week and were officially advanced to potentially move additional PBM reform into law.